About this trial
France is among the countries with one of the highest suicide rates in the world, far above those of its neighboring countries \[Wasserman et al., 2012\]. Suicide is the second leading cause of death among 15-24-year-olds, just after road traffic accidents, and the leading cause of death among 25-34-year-olds. Current models emphasize the variability of suicidal trajectories and the possible fluctuation in the duration of suicidal crises: for some individuals, the crisis evolves rapidly and explosively (brief), whereas for others, distress becomes more chronic, often in connection with underlying psychiatric disorders \[Stanley, Brodsky, and Monahan, 2023\]. In this context, the concept of a 'brief suicidal crisis' is an emerging one in psychiatry. It is characterized by an acute phase of psychological vulnerability, during which the main risk is progression to suicidal behavior, but it remains a temporary and reversible psychic crisis (lasting less than 24 hours). The crisis state is marked by a sudden inability to mobilize one's usual coping resources in the face of difficulties, making the individual highly vulnerable. Nevertheless, this concept has been little described, and a better assessment seems desirable, particularly in populations consulting a psychiatrist. Indeed, around 25% of people who die by suicide had consulted a psychiatrist in the month before their death \[Luoma et al., 2002\], yet few data are available on this topic.
Primary objective is to assess the prevalence of brief suicidal crisis episodes (lasting less than 24 hours) over the past 12 months among patients attending outpatient psychiatric care and within a sample of patients from a population catchment area in the Clermont-Ferrand region.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Any adult patient consulting the psychiatrist in his/her office during the recruitment period, regardless of the reason for the consultation, and who has given consent to participate in this study.
Disqualifiers
Minor patients, or patients who refuse to participate in the study.
Patients who have already completed the self-administered questionnaires previously (e.g., a second consultation within the same week).
Patients unable to understand and complete the self-administered questionnaires (cognitive impairment, difficulty understanding French, etc.).
Trial population
patient consulting the psychiatrist in his/her office during the recruitment period
Trial design
Ecologic or community
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Risk score of brief suicidal crisis
Risque suicidaire de Ducher a (aRSD) scale score for brief suicidal crises. Minimum score 0 maximum score 10 . highter score mean worse outcome
Sponsors and contacts
Click on the lead sponsor to view all of their trials.